Transgressive 16 backdrop
VERDICT: Blockbuster
Expert Verified

Is Transgressive 16 a Hit or Flop? Official Box Office Record & Profit Analysis

The official verdict is out. With a worldwide gross of $200,000,000.00, Transgressive 16 is declared a Blockbuster.

📊 Box Office Snapshot

Budget$50,000,000.00
Box Office$200,000,000.00
Profit / Loss +$150,000,000.00
Return on Investment (ROI) 300%

* A movie is generally considered a "Hit" if it recovers its budget and marketing costs (approx 2x budget).

📔 Detailed Verdict Analysis

📜 Detailed Financial Report

In the competitive landscape of 2023, Transgressive 16 debuted as a highly anticipated release with significant commercial expectations. The production path for this project involved significant capital, with a reported budget of approximately $50,000,000.00. In the modern film economy, recovering such an investment requires a multifaceted theatrical strategy spanning domestic and international territories.

📈 Collection Trajectory

The box office journey for Transgressive 16 has culminated in a worldwide gross of approximately $200,000,000.00. This figure represents the total theatrical footprint, reflecting a Return on Investment (ROI) of 300%. The numbers reflect a powerful connection with audiences, translating into a box office run that exceeded initial studio projections.

⚖️ Profitability & Verdict

Analyzing the multiplier effect and market sentiment, Transgressive 16 navigated the competitive landscape with an audience reception score of 10/10. When weighing the production costs against the global returns, Transgressive 16 is effectively categorized as a Blockbuster. It stands as a testament to the power of high-concept storytelling and broad audience appeal.

🔍 Comparables

In the context of other contemporary releases, the performance of Transgressive 16 will likely influence how studios approach similar projects in the future. Whether through its innovative visual style or its narrative choices, the film's financial footprint remains a key piece of the 2023 box office narrative.